Heavy Metal Toxicity, Health Risk Assessment, and Arsenic Leukemia Treatment
This research community investigates the biological effects of heavy metal exposure on human and animal health, quantifies the associated risks in environmental and dietary sources, and studies the therapeutic use of arsenic compounds for specific blood cancers.
The work centers on the toxicology of lead, arsenic, cadmium, and chromium, frequently examining oxidative stress mechanisms and signaling pathways in cell and animal models. A significant portion of the literature focuses on risk assessment methodologies applied to drinking water, groundwater, and food sources to determine human health hazards. Distinct from the environmental toxicity focus, a substantial strand of research details the clinical application of arsenic trioxide in the treatment of acute promyelocytic leukemia and other myeloid leukemias. These studies often utilize Wistar rats and human cell lines to model exposure effects, while clinical papers track blood lead levels and treatment outcomes. The community bridges environmental science and clinical hematology, linking environmental contamination data with specific oncological therapies.
The community represents a significant share of research in arsenic (21.3%), cadmium (18.2%), and chromium (10.5%). Arsenic also contributes the highest number of papers within this group, with 15,406 entries.
The community comprises 75,692 papers, published primarily in Biological Trace Element Research, Environmental Health Perspectives, and Ecotoxicology and Environmental Safety.
Recent work continues to focus on the mechanisms of lead toxicity, health risk assessments of heavy metals in water and dietary exposures, and the environmental forensics of metal pollution in aquaculture and drinking water systems.